Human proof for vasoactive intestinal peptide spans respiratory failure trials, chronic lung illness scientific studies, CIRS cohorts, and observational biomarker knowledge — a broader scientific proof foundation than most peptides in present study.Just with outcome sizes thirty–40% more com